• Significant bioavailability results were reported from LXRP’s randomized, double-blind European study that evaluated its proprietary TurboCBD capsules, powered by DehydraTECH
• Results corroborate and confirm in vitro and in vivo studies of DehydraTECH technology that measured high levels of drug delivery being achieved faster than with matching controls
• LXRP says that it is pleased that DehydraTECH has, to date, repeatedly proved evidence of success within human studies; technology earlier demonstrated ability to deliver nicotine

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is pleased to report significant bioavailability results from its randomized and double-blind European human clinical study of DehydraTECH™ powered TurboCBD™ and cannabidiol (CBD) fortified hemp oil capsules (http://ibn.fm/rPBS5). The new study evaluated the speed and degree of CBD absorption into blood plasma and included cardiovascular and cognitive enhancement in male volunteers.

Results corroborate and confirm earlier in vitro and in vivo studies that evaluated DehydraTECH’s platform and measured higher levels of drug delivery achieved quicker than controls with matching CBD amounts. LXRP said that it believes nearly identical bioavailability enhancement results would be shown if the cannabinoid was THC instead of CBD.

Based in British Columbia, Canada, LXRP is a biotechnology company that out-licenses its disruptive delivery technology to promote healthier ingestion methods. LXRP holds a patent for oral delivery of all cannabinoids and has a growing IP portfolio. DehydraTECH is its proprietary absorption technology platform.

In the six hours of the latest study, LXRP’s TurboCBD capsules delivered more CBD to the blood than the positive control capsules at each time point in the study up to its completion.

According to an article published by CFN Media Group, LXRP has applied for a patent to the USPTO, because, in lab studies, the proprietary technology may have proved itself capable of transporting active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier (http://ibn.fm/jhx1Z).

That barrier blocks blood-borne circulating toxins and is a challenge to researchers trying to deliver APIs in medications. The barrier serves as a significant hindrance for drug treatment of diseases of the central nervous system. In lab tests, DehydraTECH was able to transport more nicotine to the brain tissue, conjugating or joining with APIs for maximum delivery.

LXRP has been conducting in vivo lab studies on animals to, in part, determine DehydraTECH’s ability to deliver enhanced levels of nicotine to the bloodstream and brain tissue. The studies found that this platform was able to deliver up to 560 percent greater amounts of nicotine to the brain tissue compared to controls without DehydraTECH. Originally, the tests were focused on developing products for nicotine replacement (http://ibn.fm/PJVMI).

These studies demonstrated that the DehydraTECH platform could effectively transport drugs, in this case nicotine, across the blood brain barrier. As a result, LXRP filed for a patent for DehydraTECH’s innovative treatment options for diseases and disorders including Alzheimer’s, Huntington’s and Parkinson’s. LXRP hopes to leverage this future possible patent to commercialize its development of future new products that treat central nervous system diseases.

For more information, visit the company’s website at www.LexariaBioscience.com

• FinCanna’s royalty finance model could be a game changer for companies needing capital while operating in the U.S. medical cannabis space
• Pilot marketing program offering HIPAA-compliant point-of-sale solution and inventory tracking system launched in California’s medical cannabis marketplace
• The U.S. medical cannabis market is projected to grow at 11.8 percent CAGR through 2025 from $5.1 billion to an estimated $12.5 billion in 2025 (New Frontier Data)

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company focused on becoming the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry, continues to gain momentum as it invests in top-tier cannabis-related companies. FinCanna’s royalty model is a viable capital solution for U.S. businesses in the licensed medical cannabis sector as the company invests capital for a percentage of future revenues. FinCanna president and CEO Andriyko Herchak notes that the royalty model has been very successful in other industries and brings a uniquely effective approach to funding issues plaguing the U.S. cannabis marketplace.

“Our royalty model allows operators and business owners to preserve their ownership stake, not diluting themselves as they would with typical equity financing,” Herchak stated in an interview with CFN Media (http://ibn.fm/ct6xU). “Banks and federally regulated institutions are largely on the sidelines, so debt financing is difficult to find. Equity financing, as I mentioned earlier, often comes with unfavorable terms for the company. So, our royalty model fills a void in the market for companies needing capital while operating in the U.S. cannabis space.”

FinCanna’s royalty model benefits include flexibility to meet specific business needs, preservation of equity, alignment of economic interests, tax efficient protocol, timely access to capital and autonomy for the investee. FinCanna recently announced that its portfolio investee – ezGreen Compliance – is already onboarding multiple customers shortly after launching its pilot marketing program that focuses on complying with federal health privacy issues during point-of-sale and inventory procedures.

ezGreen Compliance helps its customers successfully navigate through state-by-state license, tax and compliance issues by ensuring that patients’ confidential data is being handled properly while meeting the Health Insurance Portability and Accountability Act (HIPAA) and state privacy laws, a news release states (http://ibn.fm/aWen8). ezGreen Compliance provides a proven, state-of-the-art enterprise compliance and point-of-sale software solution for licensed medical cannabis dispensaries and cultivators.

“ezGreen has made excellent progress in a very short amount of time in securing partnerships and putting itself in position to become an industry leader in the U.S. cannabis compliance category,” Herchak added. “With its proven pharma-grade compliance solution, we believe they will continue to gain momentum and establish themselves as a leader in their category.”

The FinCanna royalty portfolio includes investments in Cultivation Technologies, Inc. (“CTI”), which owns Coachella Manufacturing, one of the first companies to operate a legal solvent extraction facility for cannabis in California. CTI provides infrastructure, technology, manufacturing and branding to the legal medical cannabis industry, which includes premium medical cannabis products, concentrates and vape cartridges (http://ibn.fm/QXfeA). The company also owns six acres in Coachella, California, which is entitled for an 111,500 square foot facility featuring cultivation centers, manufacturing facilities, a testing lab, a distribution hub and a centralized processing center.

FinCanna’s third investment to date is in Refined Resin Technologies Inc., which is currently retrofitting a large, state-of-the-art medical cannabis extraction laboratory in Oakland, California. Refined Resin’s business will focus on extracting high quality cannabis distillate for white labeling services to licensed major brands and infused product manufacturers that do not have direct access to compliant production facilities (http://ibn.fm/B3nXg).

“The Refined Resin team has very deep connections in the distribution and retail markets and are themselves very effective brand developers and marketers,” Herchak noted. “Moreover, the potential capacity of the facility, and its ability to produce high value-add products bode well for the financial future of the enterprise and commensurately, outstanding value for FinCanna shareholders.”

FinCanna is building its diversified portfolio of royalty investments in scalable, best-in-class projects and companies in the U.S. medical cannabis sector, with a distinct focus on California.

For more information, visit the company’s website at www.FinCannaCapital.com

• Rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle”
• Company recently completed four new drill holes in search for gold on secured property in Argentina’s northern Patagonian region
• Up to 600 core samples are being shipped to a certified laboratory for assay, with management optimistic about “favorable results”

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) is awaiting official assay results from hundreds of core samples taken during its diamond core drilling program at the San Roque property in the Rio Negro province of Argentina.

The San Roque project is jointly owned by Marifil’s wholly owned subsidiary, Marifil Mines S.A. (51 percent), and NovaGold Argentina Inc., a wholly owned subsidiary of Novagold Resources Inc. (TSX: NG) (49 percent), with Marifil serving as the project operator of the drilling campaign. The company’s primary focus is on exploring for gold, cobalt and lithium – three metals that the world is rapidly consuming and anxiously seeking (http://ibn.fm/YRf6J).

Following the successful completion of the drilling program at San Roque, there is still much yet to be done, Marifil Vice President Richard Walters stated in a news release detailing the exploration efforts (http://ibn.fm/srFWt). Walters, a certified professional geologist by the American Association of Professional Geologists and a qualified person by Canadian National Instrument 43-101, said that the company is “hopeful for some favorable results.”

The drill cores taken during Marifil’s recent campaign are undergoing geological reporting procedures to retrieve data. Core sampling, involving sawing the product in half lengthways, is underway by field crews still in place. One half of each core will be shipped to labs in Mendoza, Argentina, for assay. The company expects to ship core samples from a selection of about 600 entries that includes blanks, standards and duplicate samples to ensure a very careful and systematic quality assurance/quality control program on the drill cores.

“The drilling at our flagship asset at San Roque has been highly anticipated by the Company and its stakeholders for many years,” Marifil President and CEO Robert Abenante stated in a June 6 press release announcing the resumption of drilling at the property (http://ibn.fm/yLSe7). “Positive results at San Roque have the ability to significantly increase the fundamental value of the Company and bring the Property one step closer to being considered an economic minerals deposit.”

San Roque is located near the Atlantic coast in southwestern Argentina within an area of excellent infrastructure. It is an advanced exploration stage project involving discovery of an epithermal polymetallic deposit of sulfide minerals where gold and zinc are of principal economic focus. The property is secured by 42,320 hectares of mine rights, of which 9,449 are patented mining claims covering all known mineralization. Importantly, the mine rights are free of any non-governmental production royalties. Historical drilling on the San Roque property totals 15,837 meters with 108 holes.

Once all assays from June’s drilling campaign are reviewed by the independent laboratory and the quality assurance/quality control analysis has been completed, Marifil intends to report the results.

“This is an exciting drilling campaign, which has the potential to vividly enhance the value perception of the Property,” Walters stated in the release. “It is clear to the team of geologists that a large volume of rock is well mineralized.”

For more information, visit the company’s website at www.MarifilMines.com

• Cannabis Strategic Ventures working toward fully reporting status with SEC, OTC exchange
• Company’s portfolio includes professional staffing services, high-quality cannabis oils
• Cannabis industry expected to be responsible for more than 600,000 jobs by 2025

Cannabis Strategic Ventures, Inc. (OTC: NUGS) has pursued its mission to foster legalized cannabis industry value-adds by building a portfolio of vertically integrated companies, and now the company is preparing to uplist on the public markets by refocusing its efforts on bringing its financial reporting up to par.

“While building on our business portfolio is very important to us, bringing the Company up to fully reporting status and up listing to a higher OTC Markets tier is also a top priority,” Cannabis Strategic Ventures CEO Simon Yu stated in a recent news release (http://ibn.fm/fcMYL). “We believe it is important to provide the reliable and transparent information to our shareholders.”

The company announced on July 26 that it had finished the financial audits for fiscal years 2016 and 2017 and is now in the process of filing full financial reports and completing its audit for the fiscal year ended March 31.

As Cannabis Strategic Ventures achieves fully reporting status with the Security and Exchange Commission (SEC), it also hopes to gain greater recognition and a stronger investment base on the higher-tier exchange, which could be beneficial to current stock holders.

The company’s mission is to build a profitable enterprise in the $10 billion cannabis and $900 million hemp industries by building brands that support all facets of business operations in those markets. Within the next seven years, employment in the cannabis industry across the United States is expected to triple from 200,000 people to 630,000, according to New Frontier Data research cited by The Desert Sun (http://ibn.fm/GXYfG). The ancillary industry effect is expected to be much more widespread. In 2017, California — the leading marijuana employer state — reported 38,233 jobs directly tied to the cannabis industry and 18,165 jobs in “related” avenues, according to Arcview Market Research. Over the next three years, the cannabis industry is expected to create nearly one job for every 1,000 people in the country.

That’s encouraging news for Cannabis Strategic Ventures as it works to build on the non-cannabis employment and staffing services provided by the company’s subsidiary, Worldwide Staffing Group, Inc., in order to expand its business operations further into the cannabis staffing arena with an emphasis on the California markets. NUGS’ BudHire subsidiary provides outsourced employment service crafted to meet the needs of cannabis-related businesses by matching qualified candidates to temporary, seasonal and permanent cannabis production staffing opportunities. It also provides human resources consulting and other professional employment services to the cannabis industry.

Pure Applied Sciences Inc., another of the company’s subsidiaries, produces high-quality cannabis oils that conform with good manufacturing practices protocols (cGMP) and the guidelines for active pharmaceutical ingredients (API) in the United States. The oils are marketed under its PureOrganix brand.

For more information, visit the company’s website at www.CannabisStrategic.com

• Asphalt Ridge processing and extraction facility debuts
• Cost-effective technology set to unlock 87 million BOE
• Formal application submitted to Nasdaq

There are oil and gas companies and there are tech companies, and, while Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) may be a bit of both, this is a corporation focused more on the high-margin commercialization of its licensing technology than its oil commodities business. The company has developed an environmentally safe, continuous flow, closed loop technology – the first in North America and probably the world – that is capable of extracting bitumen from oil sands. It recently commissioned a processing and extraction plant at Asphalt Ridge in the Uintah Basin of Utah that will, initially, have the capacity to produce 1,000 barrels per day of bitumen. Although it will generate cash flow from the endeavor, Petroteq expects to get the bulk of its future revenues from licensing its innovative oil sands technology.

The Petroteq technology is the result of almost five years of scholarship by the company’s research and engineering teams, led by its chief technology officer, Dr. Vladimir Podlipskiy. It’s technology that’s safe for the environment, depending on a patented solvent/surfactant that produces no greenhouse gases. It’s also safe to produce, since it requires no high temperatures or pressures. The technology can be effectively applied to both “water-wet” deposits, such as the oil sands projects in Alberta, Canada, and in the 20 or so countries around the globe with oil sands, as well as the “oil-wet” deposits found in Utah, where the company has its extraction facility.

Petroteq’s patented Liquid Extraction System is also cost-effective in the current oil market, producing a barrel of oil equivalent (BOE) at around $22.00. It is set to unlock an estimated 87 million BOE at Asphalt Ridge and could find application extracting Utah’s 32 billion BOE. The company plans to license the technology globally. Its proof-of-concept is the extraction plant at Asphalt Ridge.

Petroteq’s Temple Mountain Mine mineral lease at Asphalt Ridge covers over 2,500 acres in northeastern Utah, with an estimated 139.5 million gross barrels of bitumen, as disclosed in an independent resource evaluation report prepared by Chapman Petroleum Engineering Ltd. in 2015 in accordance with the Canadian Oil and Gas Evaluation Handbook (COGEH). Of this gross volume of bitumen in place, Chapman estimated that 87.8 million barrels would, under favorable circumstances, support very positive mining economics. These 87.8 million barrels would be classified as a “Contingent Resource” under current NI 51-101 and COGEH criteria.

Petroteq’s environmentally friendly heavy oil processing and extraction plant located at Asphalt Ridge debuted in June (http://ibn.fm/rPHAJ). The initial goal is to get up to a capacity of 1,000 barrels per day very soon. Thereafter, subject to having sufficient capital, Petroteq’s goal is for the plant to produce as much as 2,000 barrels of oil per day (BOD) by year-end 2019 and 5,000 BOD by year-end 2020.

In July, Petroteq announced that it had submitted an application to have the company listed on the Nasdaq Capital Market (http://ibn.fm/L07c7).

“We believe up-listing in the U.S. from the OTC Market to the NASDAQ Capital Market will increase awareness of Petroteq in the financial community,” David Sealock, CEO of Petroteq, stated in a news release. “We believe that a NASDAQ listing will help unlock some of the shareholder value we are trying to create for our stakeholders. A NASDAQ listing should provide us with more liquidity and a larger pool of investors that use the NASDAQ Stock Market as a requirement for assembling portfolio.”

For more information, visit the company’s website at www.Petroteq.energy

• CBD division offers potential for shareholders, as shared on MoneyTV
• Over 70 retail establishments offering ChineseHempOil.com products in Los Angeles
• Ground work for wholly owned subsidiary focused on CBD products began in 2016
• Continued commitment to cryptocurrency education for the Chinese-speaking community worldwide

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company focused on providing financial information and services to the Chinese-speaking community worldwide, will soon spin off its cannabis-related products into the wholly owned subsidiary ChineseHempOil.com, Inc. The spinoff was originally scheduled for May 31, 2018, but was temporarily postponed as CIIX continues to develop domestic sales channels.

CEO Warren Wang joined Donald Baillargeon on MoneyTV to discuss CIIX’s CBD division and share new developments and the potential that this investment has for shareholders (http://ibn.fm/U1SXy). This new subsidiary has two offices, one in China focused on cosmetics and CBD infusion and the other in Los Angeles, California, selling CBD oil for Chinese consumers. In the interview, Wang highlighted CIIX’s three divisions as being centered on hemp oil, Chinese investors and cryptocurrency. The focus of the conversation was on the unique opportunity in which the hemp oil division is positioned. Wang stated, “My idea is to spin off the hemp oil division hopefully by end of the year.” The full interview can be found at www.MoneyTV.net.

Though Wang describes CBD products and education as personal passions, the company is too diversified to focus all of his attention in that direction. CIIX is the first company to educate the Chinese consumer on the benefits of CBD, starting first in the U.S. and then expanding. Whether the conversation is around CBD, cryptocurrency or investing, CIIX remains dedicated to providing the best education available to Chinese-speaking investors.

Earlier this year, CIIX appointed Nina Wang as vice president of sales for U.S. consumer retail/e-commerce. Through her efforts, ChineseHempOil.com has developed strategic relationships with over 70 retail establishments in the Los Angeles area. Plans are in place to expand product placement into Northern California, furthering the process to complete the spin-off of all hemp-related assets (http://ibn.fm/qpAWQ). Wang stated in his interview with MoneyTV that the goal for the next year, in addition to the successful spin-off, is to increase brand awareness.

The company first started laying the groundwork to capitalize on the growing demand for cannabidiol-based nutrition and health products in 2016. In 2017, ChineseCBDoil.com was launched, offering the first online CBD health product store in the Chinese language. Soon after, a ‘Yelp’ style social media application available in the Apple App Store was launched as a database of marijuana dispensaries and cannabis strains to provide consumers with a database of reviews and locations. The planned spinoff of such assets will allow CIIX to focus on its new cryptocurrency division and its core financial education division while simultaneously allowing ChineseHempOil.com to expand within the rapidly growing cannabis industry.

CIIX is committed to cryptocurrency education for the Chinese-speaking community. The company provides education opportunities by broadcasting daily videos from the NYSE titled ‘Bitcoin MultiMillionaire,’ broadcasting the television program ‘Bitcoin Talk Show’ with a reach of over 500,000 Chinese people in North America, redistributing Chinese translations of The Bad Crypto Podcast and offering cryptocurrency trading courses online in both English and Chinese through its newly established Bitcoin Trading Academy LLC. These are just some of the strategic ways in which CIIX has set itself apart as the leading financial information website for Chinese-speaking investors globally.

For more information, visit the company’s website at www.ChineseInvestors.com

• Zacks Small-Cap Research Report ups fair market value of PBIO stock by $2 per share
• Collaborative development project focused on liquid food preservation without chemical additives, extended shelf-life at room temperature and greater safety based upon PBIO’s patented Ultra Shear Technology (“UST”), as announced by Ohio State University and PBIO
• Unique UST pressure processing technology platform can be applied across many lucrative industries in addition to food, including pharmaceutical, nutraceutical, industrial lubricants, paint and cosmetic sectors
• Non-thermal processing market estimated at $818.6 million in 2017, projected to reach $1.22 billion by 2022 at a CAGR of 8.4 percent from 2017
• Widening applicability of high pressure processing equipment and government grants toward development of shelf-stable food technologies a major factor in growth of food and beverage processing industry

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products in the worldwide life sciences industry, is forecast to grow at a compound annual growth rate (CAGR) of 76 percent in the next five fiscal years from 2018 to 2022, according to a Zacks Research Report issued on July 26, 2018 (http://ibn.fm/DuQR3). In the Zacks Small-Cap Research Report, the company’s fair value for PBIO shares is raised to $12/share from a previous $10/share. Zacks’ optimism regarding Pressure BioSciences is tied to a number of recent achievements and collaborative research programs, expansion of the company’s sales and marketing capabilities and a newly established multinational co-marketing partner, ISS Inc.

Pressure BioSciences is a Massachusetts-based company that manufactures high-pressure-based equipment and laboratory instrumentation for the life sciences industry. Its patented Ultra Sheer Technology (“UST”) offers the potential to produce highly stable, clean and cost-effective nanoemulsions that facilitate the production of food products with enhanced shelf lives and without the need for chemicals or preservatives, as the company noted in a recent article (http://ibn.fm/Pcr8i). The company believes that its UST technology platform can be applied across a multitude of industries seeking to satisfy consumer demand for chemical- and preservative-free food products that have longer shelf-life, greater safety and do not require refrigeration until opened.

As the Zacks report points out, PBIO and its patented high pressure, ultra-shear technology could potentially be used by liquid food and beverage makers to offer healthier drinks and juices by reducing heat exposure in the preservation process. Introducing a combined application of elevated pressure, intense shear forces and controlled times and temperatures – without exposing liquid foods and beverages to taste-destroying levels of heat – means that foods such as milk, other dairy products and juices could be packaged and preserved for transportation and longer-term storage without the need for refrigeration.

Researchers at Ohio State University, along with their PBIO collaborators, recently announced the U.S. Department of Agriculture’s National Institute of Food and Agriculture has awarded a four-year, $891,000 grant to the university to develop a new manufacturing technology to preserve liquid food and beverages based on PBIO’s ultra-shear technology (http://ibn.fm/4fSV6). Ohio State has granted PBIO a $318,000 sub-contract to build a working benchtop instrument and a pilot plant floor model UST machine. PBIO has already begun work on this project.

The primary goal of the program is to develop and make available for commercialization a continuous-flow manufacturing technology that will prepare liquid foods and beverages with a preservation process that not only retains nutritional qualities but delivers room temperature shelf stability without requiring refrigeration or chemical additives. UST offers the potential to satisfy this long sought-after demand by food processors while meeting consumer expectations for tasty, safe and shelf-stable liquid foods and beverages, as PBIO stated in a July 19 news release (http://ibn.fm/gnzxT).

“The ultimate goal of this collaborative project is for consumers to benefit from the increased availability of wholesome, healthy, better-tasting, shelf-stable, clean label liquid food and beverage options,” Richard T. Schumacher, president and CEO of PBIO, said in the news release. “Imagine liquid foods like milk shipped and stored at room temperature for extended periods of time post-processing, while retaining superior nutritional and taste qualities. The advantages and cost-savings to the consumer and dairy industry could be game-changing. The advantages and cost savings to schools, the military, disaster relief agencies, and other such groups could be equally significant. This technology development is very exciting, and potentially very rewarding, for all stakeholders in PBI.”

For more information, visit the company’s website at www.PressureBioSciences.com

• Project backed by $891,000 grant from U.S. Department of Agriculture
• Ohio State gives Pressure BioSciences $318,000 contract to design and build “first-in-kind” bench-top and floor model Ultra Shear Technology equipment
• Game-changing technology could provide cost-effective methods of preserving milk, other dairy products and juices at room temperature and without the need for chemical preservatives

Pressure BioSciences Inc. (OTCQB: PBIO), a leading developer of innovative pressure-based solutions for the global life sciences industry, and the highly-regarded College of Food, Agricultural and Environmental Sciences (CFAES) of The Ohio State University, are collaborating to create a cost-effective and game-changing new method of allowing beverages and liquid foods to be stored at room temperature, according to a recent company press release (http://ibn.fm/Sn57d). The company believes that its Ultra Shear Technology (UST) can be scaled up to make it possible to preserve foodstuffs such as milk, other dairy products and juices without the use of additives and without compromising their look, texture or fresh taste. The company believes that UST will also allow these foods to be conveniently stored at room temperature for extended periods of time.

Combining high pressure and high shear forces while minimizing exposure to damaging high temperatures, this innovative method is expected to allow for the manufacture of healthier and better tasting products by eliminating the need for chemical preservatives and reducing thermal damage.

“The ultimate goal of this collaborative project is for consumers to benefit from the increased availability of wholesome, healthy, better-tasting, shelf-stable, clean label liquid food and beverage options. Imagine liquid foods like milk shipped and stored at room temperature for extended periods of time post-processing, while retaining superior nutritional and taste qualities,” Pressure BioSciences President and CEO Richard T. Schumacher said in a news release.

The U.S. Department of Agriculture’s National Institute of Food and Agriculture is funding the project with an $891,000 grant over four years, extended to Ohio State’s College of Food, Agricultural and Environmental Sciences. Because of its expertise in high pressure and high-pressure equipment, Ohio State sub-contracted Pressure BioSciences to create bench-top and plant floor equipment in a deal worth $318,000.

At the moment, although there are high-pressure processing (HPP) methods that extend shelf-life and reduce disease-causing microbes, these methods are expensive and non-efficient. HPP can reduce food-borne pathogens and extend shelf-life without the need for chemical additives, but it remains a batch process that’s not capable of continuous flow. Because it is only a pasteurization process that does not render food commercially sterile, HPP-processed food must be stored and shipped under refrigeration at all times. “We believe that Ultra Shear Technology will provide economical solutions to these problems, and will offer an additional, clean label processing choice to both consumers and the food industry around the world,” Pressure BioSciences’ Senior Vice President of Engineering, Dr. Edmund Y. Ting, Sr., added.

The joint Ohio State University-Pressure BioSciences program is headed by Dr. V.M. “Bala” Balasubramaniam, a professor of food engineering at CFAES who is known internationally for his research on high-pressure and other types of nonthermal processing and safe processing of food using reduced heat. “We believe UST can be used by food manufacturers for the processing of healthier and improved beverages, sauces, condiments and other foods,” he stated in a news release. Balasubramaniam works with a multidisciplinary team of chemists, microbiologists and nutritionists at Ohio State’s CFAES that investigates innovative food technologies and collaborates with industry entities to implement these technologies commercially.

The program offers the potential to bring revolutionary advantages and cost savings to the consumer and the dairy industry, but also to schools, the military, disaster relief agencies and other such groups, according to Schumacher.

He added that this promising project comes against a backdrop of positive developments for the company. “With our core business showing consistent revenue growth, our BaroFold acquisition generating revenue much sooner than planned, and our Ultra Shear Technology platform getting off to an impressive start, we believe PBIO has now positioned itself well for rapid, explosive growth in the months and years ahead.”

For more information, visit the company’s website at www.PressureBioSciences.com

• The company is working to be a major provider of premier CBD products
• ETST’S three subsidiaries focus on developing its role as a global leader in the CBD space
• ETST is forward-thinking – centering on the science, research and studies of its high-grade hemp CBD oil

Based in Doral, Florida, Earth Science Tech, Inc. (OTC: ETST) is a biotechnology company with three wholly owned subsidiaries. Through these, it operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. CBD offered by the company is in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products.

CBD is a naturally occurring constituent of industrial hemp oil. ETST is advancing its efforts to be a major provider of premier CBD products. Business Insider recently noted (http://ibn.fm/z2Jqd) that “CBD is estimated to make up a roughly $1 billion industry, but the recent federal approval could make it even more lucrative by jump-starting demand for CBD-based products.”

ETST’s wholly owned subsidiaries are Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc., and KannaBidioiD, Inc. These subsidiaries center on developing ETST’s role as an international leader in the CBD space. They also focus on expanding the company’s work in the pharmaceutical and medical device sectors.

Earth Science Pharmaceutical’s mission is to develop low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Cannabis Therapeutics’ emphasis is on developing new, pioneering, cannabinoid-based pharmaceutical and nutraceutical products. KannaBidioiD (KBD) focuses on products for the recreational cannabis space.

Furthermore, ETST has its Canadian subsidiary, Canna Inno Laboratories, Inc. (Montreal, Québec), which it acquired last year. The company established this subsidiary to give it a position in the province and to provide it with access to government grants.

ETST’s three-year strategic plan, created in 2017, includes expansion into Canada. The company recently attended the largest Cannabis Expo in Canada, the Lift and Co. Expo.

In a news release, Dr. Michel Aubé, ETST’S chief executive officer and chief scientific officer, said, “I met many leaders in the Canadian medical cannabis industry, as well as future leaders in the burgeoning legal recreational cannabis industry and visionary lenders who are active in financing cannabis industry growth. We will pursue some of these new relationships in the coming months.”

ETST is now developing three new CBD formulas that are under a provisory patent. One CBD formula product is a neuron protector and the other is a breast protector. The third CBD formula is a new kind of superfood with distinctive organoleptic properties.

ETST is moving forward concentrating on the science, research and study of its high-grade hemp CBD oil as a nutraceutical and dietary supplement. In addition, the company has completed the set-up of its scientific advisory council with a team of recognized scientists. Furthermore, it is making its entry into the medical devices market via collaborative partnerships. ETST’s management team, with decades of experience in the nutraceutical, dietary supplement and life sciences sectors, is steering the company in an exciting direction.

For more information, visit the company’s website at www.EarthScienceTech.com

• Creates branded games to capture data and gain leads and sales for clients
• Combining fun and competition triggers emotional connection that leads to longer relationships with consumers
• Gamify has accelerated merchant base growth by 61 percent

The gamification company DeepMarkit Inc. (TSX.V: MKT) (OTCQB: MKTDF) helps businesses engage consumers and other audiences by creating branded games for the capturing of data, for the purpose of gaining high-quality leads and sales. P&S Market Research estimates that the global gamification market will exceed $22 billion by 2022. DeepMarkit is taking this gamification market and turning web app visitors into loyal customers through its innovative and entertaining game design features. The company offers cutting edge solutions for e-commerce and was highlighted in a recent audio press release (http://ibn.fm/O47c7).

Digital marketing is crucial in getting customers to move from brand awareness to lifetime loyalty. Gamifying the experience combines fun and an element of competition, triggering an emotional connection that leads to a longer relationship. Games can be played anywhere there is a desktop, smartphone or tablet and allow for a natural social interaction amongst consumers and their network. They are also permission-based, eliminating the negative feelings of an audience that is overrun with daily requests for their personal information. Through the use of the DeepMarkit platform, customers are provided with fun, competition, increased socialization and earned value in exchange for the data they share.

DeepMarkit recently released Gamify, a multiplatform slide-out app that provides unique branded games with interactive advertising and powerful visuals. The Gamify platform has helped accelerate the company’s month-over-month merchant base growth by 61 percent. The app was first released for free on Shopify in February and has since become available on the e-commerce platform BigCommerce and as a plug-in for WordPress. In the coming months, more games, gamified surveys and richer features are set to be launched with the paid version of the app.

Through the Gamify platform, customers volunteer to participate in a reward loop where they earn added value that transfers into increased sales. DeepMarkit offers cutting-edge solutions for intuitive e-shopping, providing its clients with lifelong engaged customers.

For more information, visit the company’s website at www.DeepMarkit.com